7.88

0.64% 0.05

After Hours: 8.04 0.16 +2.03%

Alpha Tau Medical Ltd (DRTS)

Overview News Price History Discussions Forecast

Alpha Tau Medical Ltd stock is traded at $7.88, with a volume of 266.32K. It is up +0.64% in the last 24 hours and up +9.90% over the past month. Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Previous Close:

$7.83

Open:

$7.8

24h Volume:

266.32K

Relative Volume:

0.79

Market Cap:

$693.52M

Revenue:

Net Income/Loss:

$-42.63M

P/E Ratio:

-14.92

EPS:

-0.5281

Net Cash Flow:

$-39.43M

1W Performance:

+9.44%

1M Performance:

+9.90%

6M Performance:

+103.62%

1Y Performance:

+207.81%

1-Day Range:

$7.54

$7.95

1-Week Range:

$7.14

$7.95

52-Week Range:

$2.50

$8.60

Alpha Tau Medical Ltd Stock (DRTS) Company Profile

Name

Alpha Tau Medical Ltd

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

Address

Employee

121

Twitter

Next Earnings Date

2026-03-11

Latest SEC Filings

DRTS's Discussions on Twitter

Compare DRTS vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRTS Alpha Tau Medical Ltd	7.88	689.12M	0	-42.63M	-39.43M	-0.5281
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-04-26	Downgrade	Piper Sandler	Overweight → Neutral
Dec-15-23	Initiated	Citigroup	Buy
Apr-24-23	Initiated	H.C. Wainwright	Buy
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight
Apr-08-22	Initiated	Piper Sandler	Overweight
Apr-04-22	Initiated	Citigroup	Buy

View All

Alpha Tau Medical Ltd Stock (DRTS) Latest News

Apr 14, 2026

DRTS Options Volatility — NASDAQ:DRTS - TradingView — Track All Markets

Apr 14, 2026

DRTS Options Chain — NASDAQ:DRTS - TradingView — Track All Markets

Apr 14, 2026

Apr 13, 2026

Shorts Report: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Earnings Surprises & High Return Trade Guides - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Growth Recap: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandQuarterly Trade Review & High Conviction Investment Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

Jobs Data: Can Alpha Tau Medical Ltd continue delivering strong returnsEarnings Overview Summary & Safe Capital Preservation Plans - baoquankhu1.vn

Apr 09, 2026

Apr 07, 2026

FOMO Trade: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Geopolitical Influence & AI Based Trade Execution Alerts - baoquankhu1.vn

Apr 07, 2026

Daytona Street Capital LLC Invests $749,000 in Alpha Tau Medical Ltd. $DRTS - MarketBeat

Apr 07, 2026

Apr 04, 2026

Stop Loss: How does Alpha Tau Medical Ltd compare to its peersTrade Signal Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn

Apr 01, 2026

Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW - TipRanks

Apr 01, 2026

Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN

Apr 01, 2026

Aug Update: What is Alpha Tau Medical Ltd Equity Warrants market position2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - TipRanks

Mar 31, 2026

Aug EndMonth: Why is Alpha Tau Medical Ltd stock going down2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn

Mar 31, 2026

Alpha Tau Medical to Present First Oral Data on Alpha DaRT Technology for Pancreatic Cancer at DDW 2026 - geneonline.com

Mar 31, 2026

Alpha Tau Medical (Nasdaq: DRTS) wins DDW 2026 oral slot for Alpha DaRT pancreatic cancer trials - Stock Titan

Mar 31, 2026

Alpha Tau Announces First-Ever Oral Presentation of Alpha - GlobeNewswire

Mar 31, 2026

Mar 30, 2026

Resistance Check: Is Alpha Tau Medical Ltd forming a bullish divergenceDollar Strength & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 30, 2026

Aug Spikes: Should I invest in Alpha Tau Medical Ltd before earningsWeekly Trading Summary & Weekly Market Pulse Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Mar 29, 2026

Mar 27, 2026

Aug Ideas: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M AQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn

Mar 27, 2026

Mar 26, 2026

Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan

Mar 26, 2026

Mar 25, 2026

US Stocks Recap: What is Alpha Tau Medical Ltd Equity Warrants market positionMarket Movers & Community Verified Trade Signals - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026